Ultragenyx Pharmaceutical (RARE) Q1 2017 Earnings

16FebConfirmed
Q2 2016
Aug 16
Q4 2016
Q1 2017
-1.75
-1.6
-1.46
-1.31

Details

Expected EPS
-1.71
Actual EPS
-1.75
Surprise EPS
-0.04
Surprise Percent
+2.34%

Description

Ultragenyx Pharmaceutical (RARE) has reported earnings of -1.75 per share for Q1 2017.

0 Comments

Share your thoughts